-
targeting serogroups A, C, W-135, and Y:
three conjugate vaccines (MCV-4),
Menactra, Menveo, and Menquadfi.[citation needed] The pure
polysaccharide vaccine...
- "Hiberix". U.S. Food and Drug
Administration (FDA). 30
April 2018.
Retrieved 6 May 2020.
Menactra package insert.
Sanofi Pasteur. 26
August 2014 v0.12....
-
IMOJEV (live, attenuated)
Measles vaccines Rouvax Meningococcal vaccines Menactra, the
first meningococcal vaccine approved for use in
infants Menomune-A/C/Y/W-135...
-
Adacel (DPT vaccine)
Daptacel (DPT vaccine)
Dengvaxia (Dengue vaccine)
Menactra (Meningococcal infections)
Mycobax (Tuberculosis vaccine)
Pentacel (DTaP-IPV/Hib...
- Menomune,
Mencevax and NmVac-4) to more than
eight years (conjugate
vaccine Menactra).
Children 2–10
years of age who are at high risk for
meningococcal disease...
-
Neisvac C and Meningitec.
Serotypes A/C/W-135/Y: Mencevax, Nimenrix, Menveo,
Menactra.
Serotype B:
Bexsero Typhoid vaccine Salmonella Typhi Typhoid fever Typhim...